1Biomedical Engineering, Illinois Institute of Technology, Chicago, United States of America
2Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, United States of America
Presenting Author: Konstantinos Arfanakis
Synopsis
Motivation:
Goals:
Approach:
Results:
Full abstract & presentation
The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.
Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.
To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.
1. Yoshita M, Fletcher E, Harvey D, et al. Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD. Neurology. 2006;67(12):2192-2198. doi:10.1212/01.wnl.0000249119.95747.1f [doi]
2. de Leeuw FE, de Groot JC, Achten E, et al. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry. 2001;70(1):9-14. doi:10.1136/jnnp.70.1.9 [doi]
3. Zhuang FJ, Chen Y, He WB, Cai ZY. Prevalence of white matter hyperintensities increases with age. Neural Regen Res. 2018;13(12):2141-2146. doi:10.4103/1673-5374.241465 [doi]
4. Koohi F, Harshfield EL, Markus HS. Contribution of Conventional Cardiovascular Risk Factors to Brain White Matter Hyperintensities. Journal of the American Heart Association. 2023;12(14):e030676. doi:10.1161/JAHA.123.030676 [doi]
5. Phuah CL, Chen Y, Strain JF, et al. Association of Data-Driven White Matter Hyperintensity Spatial Signatures With Distinct Cerebral Small Vessel Disease Etiologies. Neurology. 2022;99(23):e2535-e2547. doi:10.1212/WNL.0000000000201186 [doi]
6. Biesbroek JM, Weaver NA, Biessels GJ. Lesion location and cognitive impact of cerebral small vessel disease. Clin Sci (Lond). 2017;131(8):715-728. doi:10.1042/CS20160452 [doi]
7. Birdsill AC, Koscik RL, Jonaitis EM, et al. Regional white matter hyperintensities: aging, Alzheimer’s disease risk, and cognitive function. Neurobiol Aging. 2014;35(4):769-776. doi:10.1016/j.neurobiolaging.2013.10.072 [doi]
8. Arvanitakis Z, Fleischman DA, Arfanakis K, Leurgans SE, Barnes LL, Bennett DA. Association of white matter hyperintensities and gray matter volume with cognition in older individuals without cognitive impairment. Brain Struct Funct. 2016;221(4):2135-2146. doi:10.1007/s00429-015-1034-7 [doi]
9. Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2010;341:c3666. doi:10.1136/bmj.c3666 [doi]
10. Ali DG, Bahrani AA, El Khouli RH, et al. White matter hyperintensities influence distal cortical β-amyloid accumulation in default mode network pathways. Brain and Behavior. 2023;13(10):e3209. doi:10.1002/brb3.3209 [doi]
11. Bennett DA, Buchman AS, Boyle PA, Barnes LL, Wilson RS, Schneider JA. Religious Orders Study and Rush Memory and Aging Project. J Alzheimers Dis. 2018;64(s1):S161-S189. doi:10.3233/JAD-179939 [doi]
12. Barnes LL, Shah RC, Aggarwal NT, Bennett DA, Schneider JA. The Minority Aging Research Study: ongoing efforts to obtain brain donation in African Americans without dementia. Curr Alzheimer Res. 2012;9(6):734-745. doi:10.2174/156720512801322627 [doi]
13. Nikseresht G, Evia AM, Nag S, et al. Neuropathologic correlates of cerebral microbleeds in community-based older adults. Neurobiol Aging. 2023;129:89-98. doi:10.1016/j.neurobiolaging.2023.05.005 [doi]
14. Winkler AM, Ridgway GR, Webster MA, Smith SM, Nichols TE. Permutation inference for the general linear model. Neuroimage. 2014;92(100):381-397. doi:10.1016/j.neuroimage.2014.01.060 [doi]